Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth
The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and Asia The Restructuring Program focuses Clinical Genomics on profitability and adds resources in Sterilization and Disinfection Control, Calibration Solutions and Asia
Covered in this story
What has happened since
- Mesa Laboratories Inc is up 1.2% since this was published, 9 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $MLAB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Mesa Laboratories Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.